Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Animal Health International, Inc. (NASDAQ: AHII - News)(referred to as "AHII") by Lextron, Inc. (“Lextron”) with support from investment funds affiliated with Leonard Green & Partners, L.P., (“Leonard Green”) in a cash transaction valued at approximately $111 million, plus the repayment of AHII's outstanding indebtedness, for a total purchase price of approximately $251 million.
Under the terms of the definitive agreement, Lextron will acquire all of the outstanding common shares of AHII for $4.25 per share. Investment funds affiliated with Charlesbank Capital Partners, and Jim Robison, AHII's Chairman, President and CEO, who together own approximately 33% of AHII's outstanding common stock, have agreed to vote in favor of the transaction.
Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company’s shareholders. If you are a holder of AHII stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.
If you are a shareholder of AHII and would like more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: firstname.lastname@example.org. All e-mail correspondence should make reference to AHII.Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at www.nyclasslaw.com. ATTORNEY ADVERTISING. © 2011 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41 st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter.